Abstract:Folate depletion causes chromosomal instability by increasing DNA strand breakage, uracil misincorporation, and defective repair. Folate mediated one-carbon metabolism has been suggested to play a key role in the carcinogenesis and progression of hepatocellular carcinoma (HCC) through influencing DNA integrity. Methylenetetrahydrofolate reductase (MTHFR) is the enzyme catalyzing the irreversible conversion of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate that can control folate cofactor distributions and modulate the partitioning of intracellular one-carbon moieties. The association between MTHFR polymorphisms and HCC risk is inconsistent and remains controversial in populational studies. We aimed to establish an in vitro cell model of liver origin to elucidate the interactions between MTHFR function, folate status, and chromosome stability. In the present study, we (1) examined MTHFR expression in HCC patients; (2) established cell models of liver origin with stabilized inhibition of MTHFR using small hairpin RNA delivered by a lentiviral vector, and (3) investigated the impacts of reduced MTHFR and folate status on cell cycle, methyl group homeostasis, nucleotide biosynthesis, and DNA stability, all of which are pathways involved in DNA integrity and repair and are critical in human tumorigenesis. By analyzing the TCGA/GTEx datasets available within GEPIA2, we discovered that HCC cancer patients with higher MTHFR had a worse survival rate. The shRNA of MTHFR (shMTHFR) resulted in decreased MTHFR gene expression, MTHFR protein, and enzymatic activity in human hepatoma cell HepG2. shMTHFR tended to decrease intracellular S-adenosylmethionine (SAM) contents but folate depletion similarly decreased SAM in wildtype (WT), negative control (Neg), and shMTHFR cells, indicating that in cells of liver origin, shMTHFR does not exacerbate the methyl group supply in folate depletion. shMTHFR caused cell accumulations in the G2/M, and cell population in the G2/M was inversely correlated with MTHFR gene level (r = −0.81, p < 0.0001), MTHFR protein expression (r = −0.8; p = 0.01), and MTHFR enzyme activity (r = −0.842; p = 0.005). Folate depletion resulted in G2/M cell cycle arrest in WT and Neg but not in shMTHFR cells, indicating that shMTHFR does not exacerbate folate depletion-induced G2/M cell cycle arrest. In addition, shMTHFR promoted the expression and translocation of nuclei thymidine synthetic enzyme complex SHMT1/DHFR/TYMS and assisted folate-dependent de novo nucleotide biosynthesis under folate restriction. Finally, shMTHFR promoted nuclear MLH1/p53 expression under folate deficiency and further reduced micronuclei formation and DNA uracil misincorporation under folate deficiency. In conclusion, shMTHFR in HepG2 induces cell cycle arrest in G2/M that may promote nucleotide supply and assist cell defense against folate depletion-induced chromosome segregation and uracil misincorporation in the DNA. This study provided insight into the significant impact of MTHFR function on chromosome stability of hepatic tissues. Data from the present study may shed light on the potential regulatory mechanism by which MTHFR modulates the risk for hepatic malignancies.

Folate Deficiency Induces Mitotic Aberrations and Chromosomal Instability by Compromising the Spindle Assembly Checkpoint in Cultured Human Colon Cells

Effect of Low Dietary Folate on Mouse Spermatogenesis and Spindle Assembly Checkpoint Dysfunction May Contribute to Folate Deficiency-Induced Chromosomal Instability in Cultured Mouse Spermatogonia

Folate deficiency induces aneuploidy in human lymphocytes in vitro-evidence using cytokinesis-blocked cells and probes specific for chromosomes 17 and 21.

A Comparison of Folic Acid Deficiency-Induced Genomic Instability in Lymphocytes of Breast Cancer Patients and Normal Non-Cancer Controls from a Chinese Population in Yunnan

Folate deficiency and aberrant DNA methylation and expression of FHIT gene were associated with cervical pathogenesis

Mechanism of Folate Deficiency-Induced Apoptosis in Mouse Embryonic Stem Cells: Cell Cycle Arrest/apoptosis in G1/G0 Mediated by Microrna-302A and Tumor Suppressor Gene Lats2

Parental folate deficiency induces birth defects in mice accompanied with increased de novo mutations

Effects of Folate on Telomere Length and Chromosome Stability of Human Fibroblasts and Melanoma Cells in Vitro: a Comparison of Folic Acid and 5-Methyltetrahydrofolate.

Effect of folate oversupplementation on folate uptake by human intestinal and renal epithelial cells

The Impacts of Variation of Folate Metabolic Component and MTHFR C677T Polymorphisms on Chromosome Segregation.

Folate Deficiency Drives Mitotic Missegregation of the Human FRAXA Locus

Folic Acid, Folinic Acid, 5 Methyl TetraHydroFolate Supplementation for Mutations That Affect Epigenesis through the Folate and One-Carbon Cycles

Long interspersed nucleotide element-1 hypomethylation in folate-deficient mouse embryonic stem cells

Disruption of Cytosolic Folate Integrity Aggravates Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and Modulates Metastatic Properties in Non-Small-Cell Lung Cancer Cells

Folate Metabolism Modifies Chromosomal Damage Induced by 1,3-Butadiene: Results from a Match-Up Study in China and in Vitro Experiments

Maternal folate deficiency results in selective upregulation of folate receptors and heterogeneous nuclear ribonucleoprotein-E1 associated with multiple subtle aberrations in fetal tissues

MTHFR Knockdown Assists Cell Defense against Folate Depletion Induced Chromosome Segregation and Uracil Misincorporation in DNA

Folate deficiency promotes cervical squamous carcinoma SiHa cells progression by targeting miR-375/FZD4/β-catenin signaling

Dietary and Genetic Manipulations of Folate Metabolism Differentially Affect Neocortical Functions in Mice

Abnormal transcriptome-wide DNA demethylation induced by folate deficiency causes neural tube defects

Folate Deprivation Induces Cell Cycle Arrest at G0/G1 Phase and Apoptosis in Hippocampal Neuron Cells Through Down-Regulation of IGF-1 Signaling Pathway.